News
GSK RSV vaccine Arexvy accepted for regulatory review by EMA to expand use in adults 18 years, older
London: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to ...
The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to 59 years old who are at increased risk for severe illness from ...
21h
Money Talks News on MSNOver 50? You Need These 5 Vaccines, the CDC SaysFor this reason, the CDC recommends adults 50 or older schedule the following vaccines, which many people can get for free.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results